<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K799DP4&l=dataLayer" height="0" width="0" style="display:none;visibility:hidden"></iframe>
NAS:CBAY (USA) Also Trade In: Germany UK

CymaBay Therapeutics Inc $ 4.68 -0.01 (-0.11%)

Volume:
334,127
Avg Vol (1m):
574,365
Market Cap $:
319.44 Mil
Enterprise Value $:
80.56 Mil
P/E (TTM):
0.00
P/B:
1.36
Warning! GuruFocus has detected 1 Severe warning sign with CBAY. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

5.6/10
Current Vs Industry Vs History
Cash-To-Debt 103.66
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
N/A
Piotroski F-Score 3
0
1
2
3
4
5
6
7
8
9
Beneish M-Score -3.43
Not Manipulator
Manipulator
WACC vs ROIC
ROIC 0%
WACC 10.52%

Profitability

2/10
Current Vs Industry Vs History
ROE % -40.48
ROA % -37.46
ROC (Joel Greenblatt) % -4756.65
3-Year EBITDA Growth Rate -17.4
3-Year EPS without NRI Growth Rate -14.9

Ratios

Current Vs Industry Vs History
PB Ratio 1.36
EV-to-EBIT -0.94
N/A
EV-to-EBITDA -0.95
N/A
Current Ratio 16.2
Quick Ratio 16.2

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36.3

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 1.35
Earnings Yield (Greenblatt) % -105.86